Marc Lichtenfeld

Marc Lichtenfeld — Additional Intel

Background & Career

• Author of Get Rich with Dividends, positioned as an international bestseller and a primary credibility anchor.
• Claims 25 years in the markets / income and biotech investing; nickname "The Income Guy."
• States he has tracked oil and gas lease sales for nearly two decades.
• 250,000+ readers receive his insights weekly.
• Media appearances claimed: Fox Business, The Wall Street Journal, Bloomberg, CNBC, Forbes.
• Biotech credentials: regular attendee of the JP Morgan Healthcare Conference (10+ times); claims personal relationships with biotech CEOs (one cited as a personal contact).
• Read the Big Beautiful Bill in detail (Title V, pages 139–144, Sections 50101–50105) to surface the buried lease mandate.
• Compound Income Portfolio launched 2013.
• Memorable anecdote: a stock he recommended drew troll criticism that it "smelled like pig feces" — used as a vindication moment.

How He's Positioned

• Dual persona: (1) conservative income/dividend/royalty authority (Oxford Income Letter); (2) aggressive biotech catalyst/options trader (Trigger Event Trader) — an identity tension the copy leans into.
• Income angle: a patient guru who unearths legally mandated, repeatable, documented catalysts that produce durable monthly income regardless of price direction.
• Trader angle: a biotech insider (JP Morgan conference regular, CEO relationships) who identifies "trigger events" before Wall Street reacts.

Signature Methods / Mechanisms

• Royalty & pipeline income over direct equity ("toll-booth" framing; collect a % of every barrel with no overhead).
• Government-catalyst tracking via the Big Beautiful Bill lease schedule through 2039.
• Three model portfolios: Compound Income, Instant Income, High Yield.
• "TechBio" — coined category for AI-driven drug discovery.
• "Trigger event" framework — cataloged categories of dated market catalysts (Phase 2 results, PDUFA dates, earnings, acquisitions).

Recurring Themes / Beliefs

• Adopts Buffett's "best business is a royalty" philosophy as core doctrine.
• Political chaos benefits royalty holders — they profit from the volatility itself.
• Permian Basin (~37% tapped) is the best royalty location and U.S. oil's key growth engine.
• Central-bank gold buying at 60-year highs signals a gold bull market.
• Phase 2 biotech results historically outperform FDA approval as a stock catalyst.
• Income compounding over decades beats speculation for his core demographic.

Audience

• Conservative, retirement-focused income investors; Trump-aligned; Buffett/Munger-literate non-professionals; many focused on not repeating 2008.

Last enriched by FID from 7 promo(s).

Role: Chief Income Strategist, The Oxford Club (Agora subsidiary — same parent as MTA) Known As: "The Income Guy" Years Active: ~25 years as trader + financial researcher

• Chief Income Strategist at The Oxford Club
• Built reputation primarily around dividend investing / income strategies
• 25 years as a trader and financial researcher
• Read all 870 pages of the "Big Beautiful Bill" and identified 45 legally mandated government trading calendar events

Mechanism: Position in major oil company stocks (and options) 15 days before federally mandated offshore lease sales; exit ~15 days after auction announcement. Secondary triggers: defense contract awards, infrastructure spending announcements, earnings events.

What's novel about this: The "government trading calendar" angle — 45 publicly dated market catalysts buried in the Big Beautiful Bill and Federal Register that almost no investors track. "The one place Wall Street doesn't look."

Priority Score: A proprietary ranking system for lease sale bidder companies, scored by historical participation frequency, stock movement magnitude, and consistency of outperformance around past auctions.

Service offering: 2–3 trade alerts/month, specific stock + options recommendation on same underlying, entry price, stop loss, exit alert, model portfolio.

Promise: 12 triple-digit gain opportunities in the next year.

• The 29% Account: Obscure financial vehicle averaging 29% returns over 25 years, hidden in a tax code
• The 23 Enigma: Recurring monthly anomaly on the 23rd, allegedly returning as much as $18,400/month from $5,000 stake ⚠️ high-risk claim

• Oxford Club brand + 25-year tenure = moderate foundation
• Personal origin story: thin — no "I've been in your shoes" moment
• Brand friction: income/dividend identity conflicts with high-risk options service
• Mechanism credibility: strong — public government data is verifiable
• The $18,400/month from $5,000 claim on the 23 Enigma will damage credibility with skeptical readers

• Oxford Club is under the same Agora parent umbrella as MTA's Oxford Group parent
• The "government calendar" angle is a theme MTA should be aware of — if Oxford Club is promoting this angle, it signals reader interest in government-tied catalysts
• MTA's Bryan Bottarelli has a similar mechanic (JOLTS government report loophole) — the market is receptive to this positioning
• Marc's transition from income/dividends to options trading mirrors a broader industry trend toward options education

Mechanism: Identify oil/gas royalty trusts and pipeline MLPs positioned ahead of government-mandated production catalysts (Big Beautiful Bill — 45 offshore + 36 onshore lease sales/year through 2039). Three model portfolios: Compound Income, Instant Income, High Yield.

Core positioning (BBC Oil promo, June 2026): "Trump's $4 Trigger" — the Big Beautiful Bill's buried lease mandate creates a 15-year government-backed income tailwind for royalty holders and pipeline operators, regardless of oil price direction. Entry point: $49/year.

Key proof elements used:

• Unnamed royalty: $1K in 2000 → $48K today (4,765%); 276 consecutive monthly checks
• Pipeline pick: 50,000 miles, $55B revenue, 7.45% yield raised every year since 1998
• Gold royalty: 1,108% gain 2005–2010 vs. gold's 211%
• November 2021 macro call: predicted inflation >8% within 18 months + energy as top asset class (verified)

Scoring at 8.6/10 — Marc's highest-scoring promo in vault (alongside TOT Event 7.9). Confirmed identity-alignment law: Marc on income/royalty/yield = 7.9–8.6; Marc on tech/nuclear = 2.7–3.5.

Strategic beliefs:

• Royalties > direct commodity/equity exposure (no overhead, collect % of every barrel)
• Political chaos benefits royalty holders — they profit from the volatility itself
• Permian Basin (only 37% tapped) is the single best royalty location
• Central bank gold buying at 60-year highs = gold bull market beginning
• Income compounding over decades > speculative gains for target demographic

• Author of Get Rich with Dividends, positioned as an international bestseller and a primary credibility anchor.
• Claims 25 years in the markets / income and biotech investing; nickname "The Income Guy."
• States he has tracked oil and gas lease sales for nearly two decades.
• 250,000+ readers receive his insights weekly.
• Media appearances claimed: Fox Business, The Wall Street Journal, Bloomberg, CNBC, Forbes.
• Biotech credentials: regular attendee of the JP Morgan Healthcare Conference (10+ times); claims personal relationships with biotech CEOs (one cited as a personal contact).
• Read the Big Beautiful Bill in detail (Title V, pages 139–144, Sections 50101–50105) to surface the buried lease mandate.
• Compound Income Portfolio launched 2013.
• Memorable anecdote: a stock he recommended drew troll criticism that it "smelled like pig feces" — used as a vindication moment.

• Dual persona: (1) conservative income/dividend/royalty authority (Oxford Income Letter); (2) aggressive biotech catalyst/options trader (Trigger Event Trader) — an identity tension the copy leans into.
• Income angle: a patient guru who unearths legally mandated, repeatable, documented catalysts that produce durable monthly income regardless of price direction.
• Trader angle: a biotech insider (JP Morgan conference regular, CEO relationships) who identifies "trigger events" before Wall Street reacts.

• Royalty & pipeline income over direct equity ("toll-booth" framing; collect a % of every barrel with no overhead).
• Government-catalyst tracking via the Big Beautiful Bill lease schedule through 2039.
• Three model portfolios: Compound Income, Instant Income, High Yield.
• "TechBio" — coined category for AI-driven drug discovery.
• "Trigger event" framework — cataloged categories of dated market catalysts (Phase 2 results, PDUFA dates, earnings, acquisitions).

• Adopts Buffett's "best business is a royalty" philosophy as core doctrine.
• Political chaos benefits royalty holders — they profit from the volatility itself.
• Permian Basin (~37% tapped) is the best royalty location and U.S. oil's key growth engine.
• Central-bank gold buying at 60-year highs signals a gold bull market.
• Phase 2 biotech results historically outperform FDA approval as a stock catalyst.
• Income compounding over decades beats speculation for his core demographic.

• Conservative, retirement-focused income investors; Trump-aligned; Buffett/Munger-literate non-professionals; many focused on not repeating 2008.

Last enriched by FID from 7 promo(s).